Research Impact Fund

Investing in early-stage companies with Georgia Tech-licensed intellectual property

Our Investment Criteria

01

Stage

We invest in early stage companies. Our sweet spot for initial checks is pre-seed or seed, though we'll do Series A rounds as well. We follow on in our top companies through Series A or B.

02

Thesis

We are generalist investors. We look at companies across industries (such as climate, robotics, AI, consumer, hard tech, SaaS) and business models (such as B2B, B2C, B2G).

03

What We Look For

We are looking to invest in the best and brightest Georgia Tech founders that are building unique solutions to big problems.

$5M
Assets Under Management
8
Portfolio Companies
$180M+
Total Valuation of Portfolio Companies

How We Deploy Capital

Our investment approach focuses on deploying capital into the best early-stage companies in the Georgia Tech community.

What is your check size range? Do you do follow-ons?
We write checks of up to $450k. Initial checks range from $50K to $250K and follow-on checks range from $50K to $450K. Exceptions may be made on a case-by-case basis.
What types of financings do you participate in?
We participate on all security types, including convertible notes, SAFEs and preferred equity rounds.
Do you lead deals?
At the moment we do not lead deals, so we rely on someone else coming in to price the round.
Do you have ownership targets?
Currently, we do not have ownership targets.
What does your diligence process look like?
Our investment committee meets once a month. We invite 2-3 companies to come and pitch each session. From there, we do our deep dive and make decisions on the timeline that aligns with your close date.
Does my IP license need to be secured before investment?
Yes, the license needs to be in place prior to investment. You can, however, come in to pitch prior to having the license secured as long as it will be in place before an investment closes.

Our Portfolio Companies

Dasi

AI predictive planning software for surgical/interventional treatment

Visit Website
Huxley

Wearable medical device for sleep apnea and arrhythmia diagnosis

Visit Website
Cardiosense

Wearable medical device for heart failure detection and monitoring

Visit Website
Lamarr AI

Drones + AI to identify energy efficiency improvements for building envelopes

Visit Website
Port Therapeutics

Using heat to control cell and gene therapies

Visit Website
Falcomm

Power amplifiers for wireless signal transmission

Visit Website
SoloPulse

Next generation radar, 'changing how the world sees'

Visit Website
Andson Biotech

Rapid sample prep for mass spectrometry

Visit Website
Dasi

AI predictive planning software for surgical/interventional treatment

Visit Website →
Huxley

Wearable medical device for sleep apnea and arrhythmia diagnosis

Visit Website →
Cardiosense

Wearable medical device for heart failure detection and monitoring

Visit Website →
Lamarr AI

Drones + AI to identify energy efficiency improvements for building envelopes

Visit Website →
Port Therapeutics

Using heat to control cell and gene therapies

Visit Website →
Falcomm

Power amplifiers for wireless signal transmission

Visit Website →
SoloPulse

Next generation radar, 'changing how the world sees'

Visit Website →
Andson Biotech

Rapid sample prep for mass spectrometry

Visit Website →

Investment Committee

Brian Pellegrino

Chief Investment Officer, Georgia Tech Foundation

Raghupathy Sivakumar

Chief Commercialization Officer, Georgia Tech

Thomas Saylor

Senior Advisor, Georgia Research Alliance